新興生物科技EBS

紐約證券 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 2.77
  • 3.00
  • 2.55
  • 2.94
  • 1.95
  • 2.22
  • 1.41
  • 2.31
  • 1.44
  • 1.56
icon
  • 2.26
  • 8.60
  • -15.21
  • 15.35
  • -33.73
  • 14.12
  • -36.59
  • 64.02
  • -37.78
  • 8.55
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
156,100
143,800
231,100
140,900
222,200
194,700
293,800
254,700
300,400
276,600
營業成本
72,00084,90085,90066,90088,500118,000122,600296,100144,600185,100
營業毛利
84,100
63,800
145,200
74,000
133,700
76,700
171,200
-41,400
155,800
91,500
營業費用
73,60091,70068,70072,40083,800----135,300
研發費用
10,50012,10013,50012,50015,1009,10013,80032,70015,10029,400
推銷及管理費用
46,60051,10038,90043,70052,40060,80076,60085,90084,70089,700
非經常性項目費用
-12,200-----27,200--
其他營業費用
16,50016,30016,30016,20016,30016,30016,30016,30016,20016,200
營業利益
10,500
-15,700
76,500
1,600
49,900
-9,500
64,500
-203,500
39,800
-43,800
其他收入及費用
13,900-8,100-3,700-3,70057,500-3,30086,200-42,700-3,40011,000
利息費用
11,00014,70015,20014,70014,70014,8008,30023,60024,30021,700
稅前純益
13,400
-50,700
57,600
-16,800
92,700
-27,600
142,400
-269,800
12,100
-54,500
所得稅
6,6003,9006,400-4,80024,7003,70027,60013,3003,100-5,000
稅後純益
6,800
-54,600
51,200
-12,000
68,000
-31,300
114,800
-283,100
9,000
-49,500
基本每股稅後盈餘(元)
0.13-1.040.96-0.221.25-0.582.16-5.380.17-0.95
稀釋每股稅後盈餘(元)
0.07-0.960.90-0.201.19-0.572.20-5.400.17-0.88
基本平均股數(千股)
51900.0052400.0053200.0054200.0054400.0054200.0053100.0052600.0052200.0051900.00
稀釋平均股數(千股)
56500.0052400.0056500.0054200.0057300.0054200.0055600.0052600.0052200.0051900.00
還原基本每股稅後盈餘(元)
0.13-1.040.96-0.221.25-0.582.16-5.380.17-0.95
還原稀釋每股稅後盈餘(元)
0.07-0.960.90-0.201.19-0.572.20-5.400.17-0.88
還原基本平均股數(千股)
51,90052,40053,20054,20054,40054,20053,10052,60052,20051,900
還原稀釋平均股數(千股)
56,50052,40056,50054,20057,30054,20055,60052,60052,20051,900
EBITDA(千元)
49,700-9,90098,70023,800135,10015,400170,400-212,70071,2002,500

大家都在看

HOT